loadpatents
name:-0.026320934295654
name:-0.014084815979004
name:-0.0032639503479004
Lang; Ingo Patent Filings

Lang; Ingo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lang; Ingo.The latest application filed is for "pharmaceutical formulation comprising ciclesonide".

Company Profile
4.15.30
  • Lang; Ingo - Ingelheim am Rhein DE
  • Lang; Ingo - Ingelheim DE
  • LANG; Ingo - Mainz DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Meloxicam for the treatment of respiratory diseases in pigs
Grant 11,083,731 - Lang , et al. August 10, 2
2021-08-10
Pharmaceutical Formulation Comprising Ciclesonide
App 20210106685 - AVEN; Michael ;   et al.
2021-04-15
Pharmaceutical formulation comprising ciclesonide
Grant 10,925,964 - Aven , et al. February 23, 2
2021-02-23
Meloxicam for the treatment of respiratory diseases in pigs
App 20200121692 - LANG; Ingo ;   et al.
2020-04-23
Meloxicam for the treatment of respiratory diseases in pigs
Grant 10,548,901 - Lang , et al. Fe
2020-02-04
Ciclesonide for the treatment of airway disease in horses
Grant 10,441,597 - Albrecht , et al. Oc
2019-10-15
Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
Grant 10,357,479 - Stark , et al. July 23, 2
2019-07-23
Ciclesonide for the treatment of airway disease in horses
Grant 10,258,634 - Albrecht , et al.
2019-04-16
Angiotensin II Receptor Antagonist for the Prevention or Treatment of Systemic Diseases in Cats
App 20180193317 - Stark; Marcus ;   et al.
2018-07-12
Meloxicam For The Treatment Of Respiratory Diseases In Pigs
App 20180185380 - Lang; Ingo ;   et al.
2018-07-05
Ciclesonide for the Treatment of Airway Disease in Horses
App 20180153907 - ALBRECHT; Balazs ;   et al.
2018-06-07
Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
Grant 9,949,954 - Stark , et al. April 24, 2
2018-04-24
Ciclesonide for the treatment of airway disease in horses
Grant 9,918,995 - Albrecht , et al. March 20, 2
2018-03-20
Angiotensin II Receptor Antagonist for the Prevention or Treatment of Systemic Diseases in Cats
App 20170128423 - Stark; Marcus ;   et al.
2017-05-11
Ciclesonide For The Treatment Of Airway Disease In Horses
App 20170079988 - ALBRECHT; Balazs ;   et al.
2017-03-23
Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
Grant 9,585,873 - Stark , et al. March 7, 2
2017-03-07
1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-- Piperidin-1-yl]-xanthine For The Treatment Of A Metabolic Disorder Of A Predominantly Carnivorous Non-human Animal
App 20160346288 - DE VRIES; Frerich ;   et al.
2016-12-01
Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
Grant 9,308,197 - Stark , et al. April 12, 2
2016-04-12
Ciclesonide For The Treatment Of Airway Disease In Horses
App 20150313918 - ALBRECHT; Balazs ;   et al.
2015-11-05
Angiotensin II Receptor Antagonist for the Prevention or Treatment of Systemic Diseases in Cats
App 20140288138 - Stark; Marcus ;   et al.
2014-09-25
1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-- Piperidin-1-yl]-axanthine For The Treatment Of A Metabolic Disorder Of A Predominantly Carnivorous Non-human Animal
App 20140228287 - DE VRIES; Frerich ;   et al.
2014-08-14
Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
Grant 8,772,278 - Stark , et al. July 8, 2
2014-07-08
Pharmaceutical Formulation Comprising Ciclesonide
App 20140179650 - AVEN; Michael ;   et al.
2014-06-26
Meloxicam For The Treatment Of Respiratory Diseases In Pigs
App 20140179639 - LANG; Ingo ;   et al.
2014-06-26
Ciclesonide For The Treatment Of Airway Disease In Horses
App 20140179651 - ALBRECHT; Balazs ;   et al.
2014-06-26
Funny Current (if) Inhibitors For Use In A Method Of Treating And Preventing Heart Disease In Canine
App 20140171415 - KLEY; Saskia ;   et al.
2014-06-19
Angiotensin Ii Receptor Antagonist For The Prevention Or Treatment Of Systemic Diseases In Cats
App 20130190373 - Stark; Marcus ;   et al.
2013-07-25
Inhibitors For Treating And Preventing Heart Failure In Felines
App 20130040937 - Albrecht; Balazs ;   et al.
2013-02-14
1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-- Piperidin-1-yl]-xanthine For The Treatment Of A Metabolic Disorder Of A Predominantly Carnivorous Non-human Animal
App 20110237532 - DE VRIES; Frerich ;   et al.
2011-09-29
Preparation For The Treatment Of Equine Laminitis
App 20100190805 - Bachmann; Vincent ;   et al.
2010-07-29
Meloxicam For The Treatment Of Respiratory Diseases In Pigs
App 20080280840 - LANG; Ingo ;   et al.
2008-11-13
Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
App 20080146543 - Stark; Marcus ;   et al.
2008-06-19
Use of meloxicam formulations in veterinary medicine
App 20050245510 - Friton, Gabriele ;   et al.
2005-11-03
Meloxicam for the treatment of respiratory diseases in pigs
App 20050187213 - Lang, Ingo ;   et al.
2005-08-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed